Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Cedrol may help treat inflammatory bowel disease by improving gut health and function.

Cholecystokinin may help reduce skin inflammation in psoriasis.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

JAK inhibitors effectively treat inflammatory skin diseases by targeting specific cytokine signals.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Dupilumab can both heal and cause hair loss.

Apremilast improved symptoms in patients with severe skin conditions.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.